anmelden
SLI
2.295,60
PKT
+5,77
PKT
+0,25
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.09.11 | Novartis buy | Vontobel Research | |
| 08.09.11 | UBS hold | Vontobel Research | |
| 07.09.11 | UBS outperform | Keefe, Bruyette & Woods, Inc. | |
| 07.09.11 | UBS outperform | Keefe, Bruyette & Woods, Inc. | |
| 07.09.11 | Richemont buy | Citigroup Corp. | |
| 07.09.11 | Nestlé hold | UniCredit Research | |
| 07.09.11 | Straumann underperform | Macquarie Research | |
| 06.09.11 | UBS overweight | J.P. Morgan Cazenove | |
| 06.09.11 | Zurich Insurance buy | Citigroup Corp. | |
| 06.09.11 | Nestlé buy | Banc of America Securities-Merrill Lynch | |
| 06.09.11 | Partners Group hold | Vontobel Research | |
| 06.09.11 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 05.09.11 | Zurich Insurance overweight | J.P. Morgan Cazenove | |
| 05.09.11 | UBS neutral | UBS AG | |
| 05.09.11 | ABB (Asea Brown Boveri) neutral | HSBC | |
| 05.09.11 | UBS kaufen | Die Actien-Börse | |
| 05.09.11 | Novartis buy | Vontobel Research | |
| 02.09.11 | Kühne + Nagel International buy | Deutsche Bank AG | |
| 01.09.11 | Givaudan hold | Vontobel Research | |
| 01.09.11 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 31.08.11 | Helvetia Baloise reduce | Nomura | |
| 31.08.11 | UBS halten | Hamburger Sparkasse AG (Haspa) | |
| 31.08.11 | Givaudan hold | Vontobel Research | |
| 31.08.11 | Helvetia Baloise buy | Vontobel Research | |
| 31.08.11 | SGS SA buy | Vontobel Research | |
| 31.08.11 | Nestlé buy | Vontobel Research | |
| 31.08.11 | Novartis buy | Deutsche Bank AG | |
| 30.08.11 | Sika buy | Vontobel Research | |
| 30.08.11 | Helvetia Baloise buy | Vontobel Research | |
| 30.08.11 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
| 29.08.11 | UBS outperform | Cheuvreux SA | |
| 29.08.11 | Swiss Re buy | Vontobel Research | |
| 29.08.11 | Novartis buy | Vontobel Research | |
| 26.08.11 | Novartis outperform | Exane-BNP Paribas SA | |
| 26.08.11 | Zurich Insurance buy | Deutsche Bank AG | |
| 26.08.11 | UBS buy | Nomura | |
| 26.08.11 | Swiss Life buy | Nomura | |
| 26.08.11 | Novartis buy | Société Générale Group S.A. (SG) | |
| 24.08.11 | Straumann buy | Nomura | |
| 23.08.11 | UBS verkaufen | Independent Research GmbH |